Cases & Deals

Baxter International acquires Swedish dialysis product manufacturer Gambro for US$4 billion

Clients Baxter International Inc.

Jones Day advised Baxter International Inc. on the antitrust aspects of its acquisition of Gambro AB, a privately held dialysis product company based in Lund, Sweden, for SEK26.5 billion (approximately US$4 billion).

Gambro is a global medical technology company focused on developing, manufacturing, and supplying dialysis products and therapies for patients with acute or chronic kidney disease. The acquisition gives Baxter a comprehensive dialysis product portfolio, complements Baxter's global home dialysis offerings, and positions the company to better meet the evolving needs of the large and growing dialysis market.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.